Pentoxifylline [6493-05-6]
P1755
Estimated Purity≥98%
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NamePentoxifylline [6493-05-6]
- Delivery Days Customer7
- CertificationResearch Use Only
- Estimated Purity≥98%
- FormatSoluble in water and benzene.
- Scientific DescriptionXanthine derivative; adenosine A2 antagonist, PDE inhibitor.; Azupentat, Durapental, Oxpentifylline, Rentylin, Torental, Trental, Vazofirin
- Storage InstructionAmbient
- UNSPSC12352200
References
- Fang CC, Huang JW, Shyu RS, et al. Fibrin-Induced epithelial-to-mesenchymal transition of peritoneal mesothelial cells as a mechanism of peritoneal fibrosis: effects of pentoxifylline. PLoS One. 2012;7(9):e44765. PMID: 23028611 Nowak Ł, Zurowski D, Dobrogowski J, et al. Pentoxifylline modifies central and peripheral vagal mechanism in acute and chronic pain models. Folia Med Cracov. 2012;52(1-2):83-95. PMID: 23697217 Deree J, Martins JO, Melbostad H, et al. Insights into the regulation of TNF-alpha production in human mononuclear cells: the effects of non-specific phosphodiesterase inhibition. Clinics (Sao Paulo). 2008 Jun;63(3):321-8. PMID: 18568240. Marques LJ, Zheng L, Poulakis N, et al. Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages. Am J Respir Crit Care Med. 1999 Feb;159(2):508-11. PMID: 9927365. Ward A, Clissold SP. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs. 1987 Jul;34(1):50-97. PMID: 3308412.